This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract has a ceiling value of $1,705.58 and is a Firm Fixed Price Delivery Order with a period of performance through July 2, 2024....
This federal contract award, valued at $1,090.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,702.34 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,050.21. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,113.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,705.58. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,517.16 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of medical commodities to...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $3,111.61. The contract has a completion date of July 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,558.34 with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a specialty medication, to support federal healthcare programs. The award has an ultimate completion date of November 8, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,134.25 firm fixed-price Delivery Order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 6, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...